Results 31 to 40 of about 16,378 (224)
To explore the correlations of B cell-activating factor (BAFF), aquaporin-4 antibody (AQP4-Ab) and brain-derived neurotrophic factor (BDNF) with the severity of neuromyelitis optica spectrum disorder (NMOSD).
Li Suping +5 more
doaj +1 more source
Diagnosis of multiple sclerosis: progress and challenges [PDF]
The diagnosis of multiple sclerosis (MS) is based on typical neurological symptoms and signs along with evidence of dissemination of central nervous system (CNS) lesions in space and time.
Brownlee, W +3 more
core +1 more source
Biomarkers for neuromyelitis optica: a visual analysis of emerging research trends
Neuromyelitis optica is an inflammatory demyelinating disease of the central nervous system that differs from multiple sclerosis. Over the past 20 years, the search for biomarkers for neuromyelitis optica has been ongoing.
Xiangjun Li +6 more
doaj +1 more source
Neuromyelitis optica spectrum disorder – case report
The study presents the case of a 45-year-old woman with a rare case of Devic’s disease (neuromyelitis optica – NMO) admitted to the Department of Rehabilitation in Kielce.
Grażyna Ściegienna-Zdeb +1 more
doaj +1 more source
Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorder [PDF]
Background: Multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) are autoimmune demyelinating diseases distinguished clinically by selective involvement in NMOSD of optic nerves and spinal cord. Early clinical manifestations are
Evans, David R. S. +6 more
core +1 more source
Neuromyelitis Optica Spectrum Disorder: A Case Report
Neuromyelitis optica spectrum disorder also known as Devic's disease is an autoimmune condition where the body produces antibodies against Aquaporin-4 in the astrocytes.
Prakriti Karki +4 more
doaj +3 more sources
Alemtuzumab use in neuromyelitis optica spectrum disorders: a brief case series. [PDF]
Alemtuzumab is an anti-CD52 monoclonal antibody recently licensed for use in relapsing-remitting multiple sclerosis. Here, we report our experience of its use in neuromyelitis optica (NMO) spectrum disorders.
Azzopardi, L +4 more
core +1 more source
Objektivierung von funktionellen und strukturellen Beeinträchtigungen sensorischer Afferenzen bei neuroimmunologischen Krankheitsbildern [PDF]
In dieser kumulativen Habilitationsschrift werden eigene Arbeiten zusammengefasst, die sich thematisch mit der Objektivierung sensorischer Afferenzstörungen bei neuroimmunologischen Krankheitsbildern befassen. B-mode Ultraschall, eine in der klinischen
Schmidt, Felix Alexander
core +1 more source
Relapse of Neuromyelitis Optica Spectrum Disorder Associated with Intravenous Lidocaine
Lidocaine unmasks silent symptoms and eases neuropathic pain in multiple sclerosis patients; however, the effects of lidocaine in neuromyelitis optica have never been reported.
Akiyuki Uzawa +4 more
doaj +1 more source
Brainstem involvement - frequency, presentation and outcome [PDF]
Background Myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) are present in a subset of aquaporin-4 (AQP4)-IgG-negative patients with optic neuritis (ON) and/or myelitis.
Jarius, Sven +2 more
core +1 more source

